Recall: [NMusers] FDA commissioner's blog on Modeling and Simulation

[Kimko, Holly [JRDUS]]

Kimko, Holly [JRDUS] would like to recall the message, "[EXTERNAL]  [NMusers] 
FDA commissioner's blog on Modeling and Simulation".

Re: [NMusers] FDA commissioner's blog on Modeling and Simulation

[Kimko, Holly [JRDUS]]

Hi

I wonder when the other variables (DVID>1) will be available. I see that IRP 
had been included but cannot find Nab (neutralizing antibody). May I have that 
variable values?

Best,
Holly

On Jul 29, 2017, at 4:27 PM, Wang, Yaning 
> wrote:

Dear Colleagues:

We should feel proud of what we do. Please see the encouraging blog from the 
FDA commissioner, Dr. Scott Gottlieb.

https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/


Yaning Wang, Ph.D.
Acting Director
Division of Pharmacometrics
Office of Clinical Pharmacology
Office of Translational Sciences
Center for Drug Evaluation and Research
Food and Drug Administration
Phone: 301-796-1624
Email: yaning.w...@fda.hhs.gov
Disclaimer: The contents of this message are mine personally and do not 
necessarily reflect any position of the Government or the Food and Drug 
Administration.

[NMusers] FDA commissioner's blog on Modeling and Simulation

[Wang, Yaning]

Dear Colleagues:

We should feel proud of what we do. Please see the encouraging blog from the 
FDA commissioner, Dr. Scott Gottlieb.

https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/


Yaning Wang, Ph.D.
Acting Director
Division of Pharmacometrics
Office of Clinical Pharmacology
Office of Translational Sciences
Center for Drug Evaluation and Research
Food and Drug Administration
Phone: 301-796-1624
Email: yaning.w...@fda.hhs.gov
Disclaimer: The contents of this message are mine personally and do not 
necessarily reflect any position of the Government or the Food and Drug 
Administration.